Document is current
Any future updates will be listed below
-
Authors
Weitz, Johanna
Hammerl, Lena
Halms, Theresa
Rabenstein, Andrea
Rüther, Tobias
Hasan, Alkomiet
Gertzen, Marcus
-
Funding
Funding for this research was provided by:
Universität Augsburg
- License Information
-
More Information
Article History
Accepted: 31 May 2025
First Online: 20 June 2025
Declarations
:
: No human or animal subjects were directly involved in this research.
: A.H. was or is a member of advisory boards and received paid speakership by Boehringer-Ingelheim, Lundbeck, Otsuka, Rovi, Teva (no speakership), AbbVie and Recordati. AbbVie and Advanz. He is editor of the AWMF German guidelines for schizophrenia. All other authors have no relevant financial or non-financial interests to disclose.
